Dexamethasone retrodialysis attenuates microglial response to implanted probes in vivo

Biomaterials

Volumn 87, Issue , 2016, Pages 157-169

  Kozai, Takashi D Y ^a,b,c   Jaquins Gerstl, Andrea S ^a   Vazquez, Alberto L ^a,b   Michael, Adrian C ^a   Cui, X Tracy ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CENTER FOR THE NEURAL BASIS OF COGNITION   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Blood brain barrier (BBB); Brain penetration injury; Dexamethasone; Microdialysis; Microglia; Multiphoton microscopy

Indexed keywords

BRAIN; CEREBROSPINAL FLUID; CHEMICAL ACTIVATION; DIALYSIS; SIGNAL PROCESSING; SKIN; TISSUE;

BLOOD-BRAIN BARRIER; DEXAMETHASONES; MICRO-DIALYSIS; MICROGLIA; MULTI-PHOTON MICROSCOPY;

PROBES;

CHEMOKINE RECEPTOR CX3CR1; DEXAMETHASONE; ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN PERFUSION; CONTROLLED STUDY; IN VIVO STUDY; MECHANICAL PROBE; MICRODIALYSIS; MICROGLIA; MORPHOLOGY; MOUSE; MULTIPHOTON MICROSCOPY; NEUROLOGICAL DIAGNOSTIC DEVICE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TISSUE REACTION; ANIMAL; BRAIN; COMPLICATION; DEVICES; DRUG EFFECTS; HEAD INJURIES, PENETRATING; INFLAMMATION; PATHOLOGY; PROSTHESES AND ORTHOSES; TRANSGENIC MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN; DEXAMETHASONE; HEAD INJURIES, PENETRATING; INFLAMMATION; MICE, TRANSGENIC; MICRODIALYSIS; MICROGLIA; PROSTHESES AND IMPLANTS;

EID: 84958958498     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.02.013     Document Type: Article

References (108)

1. Kozai T.D.Y., Du Z., Gugel Z.V., Smith M.A., Chase S.M., Bodily L.M., et al. Comprehensive chronic laminar single-unit, multi-unit, and local field potential recording performance with planar single shank electrode arrays. J. Neurosci. Methods 2015, 242:15-40.
2. Kozai T.D.Y., Vazquez A.L. Photoelectric artefact from optogenetics and imaging on microelectrodes and bioelectronics: new challenges and opportunities. J. Mater. Chem. B 2015, 3:4965-4978.
3. Kozai T., Alba N., Zhang H., Kotov N., Gaunt R., Cui X. Nanostructured coatings for improved charge delivery to neurons. Nanotechnology and Neuroscience: Nano-electronic, Photonic and Mechanical Neuronal Interfacing. New York, NY 2014, 71-134. Springer, New York. M.D. Vittorio, L. Martiradonna, J. Assad (Eds.).
4. Schwartz A.B., Cui X.T., Weber D.J., Moran D.W. Brain-controlled interfaces: movement restoration with neural prosthetics. Neuron 2006, 52:205-220.
5. Kipke D.R., Shain W., Buzsaki G., Fetz E., Henderson J.M., Hetke J.F., et al. Advanced neurotechnologies for chronic neural interfaces: new horizons and clinical opportunities. J. Neurosci. 2008, 28:11830-11838.
6. Buzsaki G., Anastassiou C.A., Koch C. The origin of extracellular fields and currents-EEG, ECoG, LFP and spikes. Nat. Rev. Neurosci. 2012, 13:407-420.
7. Robinson T.E., Justice J.B. Microdialysis in the Neurosciences: Techniques in the Behavioral and Neural Sciences 2013, Elsevier.
8. Davies M.I., Cooper J.D., Desmond S.S., Lunte C.E., Lunte S.M. Analytical considerations for microdialysis sampling. Adv. Drug Deliv. Rev. 2000, 45:169-188.
9. Watson C.J., Venton B.J., Kennedy R.T. In vivo measurements of neurotransmitters by microdialysis sampling. Anal. Chem. 2006, 78:1391-1399.
10. Westerink B.H., Cremers T.I. Handbook of Microdialysis: Methods, Applications and Perspectives 2007, Academic Press.
11. Bellander B.M., Cantais E., Enblad P., Hutchinson P., Nordstrom C.H., Robertson C., et al. Consensus meeting on microdialysis in neurointensive care. Intensive Care Med. 2004, 30:2166-2169.
12. Bosche B., Dohmen C., Graf R., Neveling M., Staub F., Kracht L., et al. Extracellular concentrations of non-transmitter amino acids in peri-infarct tissue of patients predict malignant middle cerebral artery infarction. Stroke 2003, 34:2908-2913.
13. Schlenk F., Frieler K., Nagel A., Vajkoczy P., Sarrafzadeh A.S. Cerebral microdialysis for detection of bacterial meningitis in aneurysmal subarachnoid hemorrhage patients: a cohort study. Crit. Care 2009, 13:R2.
14. Sakowitz O.W., Stover J.F., Sarrafzadeh A.S., Unterberg A.W., Kiening K.L. Effects of mannitol bolus administration on intracranial pressure, cerebral extracellular metabolites, and tissue oxygenation in severely head-injured patients. J. Trauma Acute Care Surg. 2007, 62:292-298.
15. Sakowitz O.W., Unterberg A.W. Detecting and treating microvascular ischemia after subarachnoid hemorrhage. Curr. Opin. Crit. Care 2006, 12:103-111.
16. Sarrafzadeh A.S., Sakowitz O.W., Kiening K.L., Benndorf G., Lanksch W.R., Unterberg A.W. Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid hemorrhage patients?. Crit. Care Med. 2002, 30:1062-1070.
17. Strong A.J., Boutelle M.G., Vespa P.M., Bullock M.R., Bhatia R., Hashemi P. Treatment of critical care patients with substantial acute ischemic or traumatic brain injury. Crit. Care Med. 2005, 33:2147-2149.
18. Strong A.J., Hartings J.A., Dreier J.P. Cortical spreading depression: an adverse but treatable factor in intensive care?. Curr. Opin. Crit. Care 2007, 13:126-133.
19. Nordström C.-H. Cerebral energy metabolism and microdialysis in neurocritical care. Child's Nerv. Syst. 2010, 26:465-472.
20. Obrenovitch T., Richards D., Sarna G., Symon L. Combined intracerebral microdialysis and electrophysiological recording: methodology and applications. J. Neurosci. Methods 1993, 47:139-145.
21. Dreier J.P., Woitzik J., Fabricius M., Bhatia R., Major S., Drenckhahn C., et al. Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 2006, 129:3224-3237.
22. Jaquins-Gerstl A., Michael A.C. A review of the effects of FSCV and microdialysis measurements on dopamine release in the surrounding tissue. Analyst 2015, 140:3696-3708.
23. Benveniste H., Diemer N.H. Cellular reactions to implantation of a microdialysis tube in the rat hippocampus. Acta Neuropathol. 1987, 74:234-238.
24. Clapp-Lilly K.L., Roberts R.C., Duffy L.K., Irons K.P., Hu Y., Drew K.L. An ultrastructural analysis of tissue surrounding a microdialysis probe. J. Neurosci. Methods 1999, 90:129-142.
25. Zhou F., Zhu X., Castellani R.J., Stimmelmayr R., Perry G., Smith M.A., et al. Hibernation, a model of neuroprotection. Am. J. Pathol. 2001, 158:2145-2151.
26. Hascup E.R., af Bjerken S., Hascup K.N., Pomerleau F., Huettl P., Stromberg I., et al. Histological studies of the effects of chronic implantation of ceramic-based microelectrode arrays and microdialysis probes in rat prefrontal cortex. Brain Res. 2009, 1291:12-20.
27. Jaquins-Gerstl A., Shu Z., Zhang J., Liu Y., Weber S.G., Michael A.C. Effect of dexamethasone on gliosis, ischemia, and dopamine extraction during microdialysis sampling in brain tissue. Anal. Chem. 2011, 83:7662-7667.
28. Nesbitt K.M., Varner E.L., Jaquins-Gerstl A., Michael A.C. Microdialysis in the rat striatum: effects of 24 h dexamethasone retrodialysis on evoked dopamine release and penetration injury. ACS Chem. Neurosci. 2015, 6:163-173.
29. Nesbitt K.M., Jaquins-Gerstl A., Skoda E.M., Wipf P., Michael A.C. Pharmacological mitigation of tissue damage during brain microdialysis. Anal. Chem. 2013, 85:8173-8179.
30. Kozai T.D.Y., Marzullo T.C., Hooi F., Langhals N.B., Majewska A.K., Brown E.B., et al. Reduction of neurovascular damage resulting from microelectrode insertion into the cerebral cortex using in vivo two-photon mapping. J. Neural Eng. 2010, 7:046011.
31. Kozai T., Langhals N., Hooi F., Kipke D. Time course of blood brain barrier disruption due to microelectrode insertion into cerebral cortex. Biomedical Engineering Society, Annual Meeting, Pittsburgh, PA Oct 7-10. 2009.
32. Kozai T.D.Y., Jaquins-Gerstl A., Vazquez A.L., Michael A.C., Cui X.T. Brain tissue responses to neural implants impact signal sensitivity and intervention strategies. ACS Chem. Neurosci. 2015, 6:48-67.
33. Kozai T.D.Y., Vazquez A.L., Weaver C.L., Kim S.G., Cui X.T. In vivo two photon microscopy reveals immediate microglial reaction to implantation of microelectrode through extension of processes. J. Neural Eng. 2012, 9:066001.
34. Kozai T.D.Y., Li X., Bodily L.M., Caparosa E.M., Zenonos G.A., Carlisle D.L., et al. Effects of caspase-1 knockout on chronic neural recording quality and longevity: Insight into cellular and molecular mechanisms of the reactive tissue response. Biomaterials 2014, 35:9620-9634.
35. Tremblay M.E., Lowery R.L., Majewska A.K. Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 2010, 8:e1000527.
36. Wake H., Moorhouse A.J., Jinno S., Kohsaka S., Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 2009, 29:3974-3980.
37. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
38. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8:752-758.
39. Purcell E.K., Seymour J.P., Yandamuri S., Kipke D.R. In vivo evaluation of a neural stem cell-seeded prosthesis. J. Neural Eng. 2009, 6:026005.
40. Kozai T.D.Y., Eles J.R., Vazquez A.L., Cui X.T. Two-photon imaging of chronically implanted neural electrodes: sealing methods and new insights. J. Neurosci. Methods 2016, 256:46-55.
41. Biran R., Martin D.C., Tresco P.A. Neuronal cell loss accompanies the brain tissue response to chronically implanted silicon microelectrode arrays. Exp. Neurol. 2005, 195:115-126.
42. Szarowski D.H., Andersen M.D., Retterer S., Spence A.J., Isaacson M., Craighead H.G., et al. Brain responses to micro-machined silicon devices. Brain Res. 2003, 983:23-35.
43. Kozai T.D.Y., Gugel Z., Li X., Gilgunn P.J., Khilwani R., Ozdoganlar O.B., et al. Chronic tissue response to carboxymethyl cellulose based dissolvable insertion needle for ultra-small neural probes. Biomaterials 2014, 35:9255-9268.
44. Kozai T.D.Y., Langhals N.B., Patel P.R., Deng X., Zhang H., Smith K.L., et al. Ultrasmall implantable composite microelectrodes with bioactive surfaces for chronic neural interfaces. Nat. Mater. 2012, 11:1065-1073.
45. Roitbak T., Sykova E. Diffusion barriers evoked in the rat cortex by reactive astrogliosis. Glia 1999, 28:40-48.
46. Jaquins-Gerstl A., Michael A.C. Comparison of the brain penetration injury associated with microdialysis and voltammetry. J. Neurosci. Methods 2009, 183:127-135.
47. Williams J.C., Hippensteel J.A., Dilgen J., Shain W., Kipke D.R. Complex impedance spectroscopy for monitoring tissue responses to inserted neural implants. J. Neural Eng. 2007, 4:410-423.
48. Karumbaiah L., Norman S.E., Rajan N.B., Anand S., Saxena T., Betancur M., et al. The upregulation of specific interleukin (IL) receptor antagonists and paradoxical enhancement of neuronal apoptosis due to electrode induced strain and brain micromotion. Biomaterials 2012, 33:5983-5996.
49. Holson R.R., Gazzara R.A., Gough B. Declines in stimulated striatal dopamine release over the first 32 h following microdialysis probe insertion: generalization across releasing mechanisms. Brain Res. 1998, 808:182-189.
50. Holson R.R., Bowyer J.F., Clausing P., Gough B. Methamphetamine-stimulated striatal dopamine release declines rapidly over time following microdialysis probe insertion. Brain Res. 1996, 739:301-307.
51. Patel P.R., Na K., Zhang H., Kozai T.D.Y., Kotov N.A., Yoon E., et al. Insertion of linear 8.4 μ m diameter 16 channel carbon fiber electrode arrays for single unit recordings. J. Neural Eng. 2015, 12:046009.
52. Seymour J.P., Kipke D.R. Neural probe design for reduced tissue encapsulation in CNS. Biomaterials 2007, 28:3594-3607.
53. Seymour J.P., Langhals N.B., Anderson D.J., Kipke D.R. Novel multi-sided, microelectrode arrays for implantable neural applications. Biomed. Microdevices 2011, 13:441-451.
54. Kozai T.D., Li X., Bodily L.M., Caparosa E.M., Zenonos G.A., Carlisle D.L., et al. Effects of caspase-1 knockout on chronic neural recording quality and longevity: Insight into cellular and molecular mechanisms of the reactive tissue response. Biomaterials 2014, 35:9620-9634.
55. Kozai T.D., Langhals N.B., Patel P.R., Deng X., Zhang H., Smith K.L., et al. Ultrasmall implantable composite microelectrodes with bioactive surfaces for chronic neural interfaces. Nat. Mater. 2012, 11:1065-1073.
56. Kozai T.D.Y., Catt K., Li X., Gugel Z.V., Olafsson V.T., Vazquez A.L., et al. Mechanical failure modes of chronically implanted planar silicon-based neural probes for laminar recording. Biomaterials 2015, 37:25-39.
57. Gilgunn P.J., Khilwani R., Kozai T.D.Y., Weber D.J., Cui X.T., Erdos G., et al. An ultra-compliant, scalable neural probe with molded biodissolvable delivery vehicle. Micro Electro Mechanical Systems (MEMS). IEEE 25th International Conference on 2012 2012, 56-59.
58. Harris J.P., Capadona J.R., Miller R.H., Healy B.C., Shanmuganathan K., Rowan S.J., et al. Mechanically adaptive intracortical implants improve the proximity of neuronal cell bodies. J. Neural Eng. 2011, 8:066011.
59. Ware T., Simon D., Liu C., Musa T., Vasudevan S., Sloan A., et al. Thiol-ene/acrylate substrates for softening intracortical electrodes. J. Biomed. Mater. Res. B Appl. Biomater. 2014, 102:1-11.
60. Kozai T.D.Y., Kipke D.R. Insertion shuttle with carboxyl terminated self-assembled monolayer coatings for implanting flexible polymer neural probes in the brain. J. Neurosci. Methods 2009, 184:199-205.
61. Kolarcik C.L., Luebben S.D., Sapp S.A., Hanner J., Snyder N., Kozai T.D., et al. Elastomeric and soft conducting microwires for implantable neural interfaces. Soft Matter 2015, 11:4847-4861.
62. Cui X., Martin D.C. Electrochemical deposition and characterization of poly (3, 4-ethylenedioxythiophene) on neural microelectrode arrays. Sens. Actuat. B Chem. 2003, 89:92-102.
63. Cui X., Martin D.C. Fuzzy gold electrodes for lowering impedance and improving adhesion with electrodeposited conducting polymer films. Sens. Actuat. A Phys. 2003, 103:384-394.
64. Cui X., Hetke J.F., Wiler J.A., Anderson D.J., Martin D.C. Electrochemical deposition and characterization of conducting polymer polypyrrole/PSS on multichannel neural probes. Sens. Actuat. A Phys. 2001, 93:8-18.
65. Kozai T.D.Y., Catt K., Du Z., Kyounghwan N., Srivannavit O., Haque R.M., et al. Chronic in vivo evaluation of PEDOT/CNT for stable neural recordings. IEEE Trans. Biomed. Eng. 2016, 63:111-119. 10.1109/TBME.2015.2445713.
66. Kolarcik C.L., Catt K., Rost E., Albrecht I.N., Bourbeau D., Du Z., et al. Evaluation of poly(3,4-ethylenedioxythiophene)/carbon nanotube neural electrode coatings for stimulation in the dorsal root ganglion. J. Neural Eng. 2015, 12:016008.
67. Bjornsson C.S., Oh S.J., Al-Kofahi Y.A., Lim Y.J., Smith K.L., Turner J.N., et al. Effects of insertion conditions on tissue strain and vascular damage during neuroprosthetic device insertion. J. Neural Eng. 2006, 3:196-207.
68. Johnson M.D., Kao O.E., Kipke D.R. Spatiotemporal pH dynamics following insertion of neural microelectrode arrays. J. Neurosci. Methods 2007, 160:276-287.
69. Kolarcik C.L., Bourbeau D., Azemi E., Rost E., Zhang L., Lagenaur C.F., et al. In vivo effects of L1 coating on inflammation and neuronal health at the electrode-tissue interface in rat spinal cord and dorsal root ganglion. Acta Biomater. 2012, 8:3561-3575.
70. Azemi E., Lagenaur C.F., Cui X.T. The surface immobilization of the neural adhesion molecule L1 on neural probes and its effect on neuronal density and gliosis at the probe/tissue interface. Biomaterials 2011, 32:681-692.
71. Zhong Y., Bellamkonda R.V. Controlled release of anti-inflammatory agent [alpha]-MSH from neural implants. J. Control. Release 2005, 106:309-318.
72. Hue C.D., Cho F.S., Cao S., Dale Bass C.R., Meaney D.F., Morrison Iii B. Dexamethasone potentiates in vitro blood-brain barrier recovery after primary blast injury by glucocorticoid receptor-mediated upregulation of ZO-1 tight junction protein. J. Cereb. Blood Flow. Metab. 2015, 35:1191-1198.
73. Luo X., Matranga C., Tan S., Alba N., Cui X.T. Carbon nanotube nanoreservior for controlled release of anti-inflammatory dexamethasone. Biomaterials 2011, 32:6316-6323.
74. Leprince L., Dogimont A., Magnin D., Demoustier-Champagne S. Dexamethasone electrically controlled release from polypyrrole-coated nanostructured electrodes. J. Mater. Sci. Mater. Med. 2010, 21:925-930.
75. Zhong Y., Bellamkonda R.V. Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes. Brain Res. 2007, 1148:15-27.
76. Wadhwa R., Lagenaur C.F., Cui X.T. Electrochemically controlled release of dexamethasone from conducting polymer polypyrrole coated electrode. J. Control Release 2006, 110:531-541.
77. Kim D.H., Martin D.C. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials 2006, 27:3031-3037.
78. Spataro L., Dilgen J., Retterer S., Spence A.J., Isaacson M., Turner J.N., et al. Dexamethasone treatment reduces astroglia responses to inserted neuroprosthetic devices in rat neocortex. Exp. Neurol. 2005, 194:289-300.
79. Shain W., Spataro L., Dilgen J., Haverstick K., Retterer S., Isaacson M., et al. Controlling cellular reactive responses around neural prosthetic devices using peripheral and local intervention strategies. IEEE Trans. Neural Syst. Rehabil. Eng. 2003, 11:186-188.
80. Williams G.A., Haller J.A., Kuppermann B.D., Blumenkranz M.S., Weinberg D.V., Chou C., et al. Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am. J. Ophthalmol. 2009, 147(1). 048-54, 54 e1-2.
81. Chang A., Eastwood H., Sly D., James D., Richardson R., O'Leary S. Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery. Hear. Res. 2009, 255:67-72.
82. Luo X., Cui X.T. Electrochemical deposition of conducting polymer coatings on magnesium surfaces in ionic liquid. Acta Biomater. 2011, 7:441-446.
83. Mitala C.M., Wang Y., Borland L.M., Jung M., Shand S., Watkins S., et al. Impact of microdialysis probes on vasculature and dopamine in the rat striatum: a combined fluorescence and voltammetric study. J. Neurosci. Methods 2008, 174:177-185.
84. Munk A., Guyre P.M., Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 1984, 5:25-44.
85. Makino S., Hashimoto K., Gold P.W. Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress. Pharmacol. Biochem. Behav. 2002, 73:147-158.
86. Reichardt H.M., Tuckermann J.P., Gottlicher M., Vujic M., Weih F., Angel P., et al. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 2001, 20:7168-7173.
87. Galicich J., French L.A. Use of dexamethasone in the treatment of cerebral edema resulting from brain tumors and brain surgery. Am. Pract. Dig. Treat. 1961, 12:169-174.
88. Avery G.B., Fletcher A.B., Kaplan M., Brudno D.S. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985, 75:106-111.
89. Bernini J.C., Rogers Z.R., Sandler E.S., Reisch J.S., Quinn C.T., Buchanan G.R. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 1998, 92:3082-3089.
90. Lukins M.B., Manninen P.H. Hyperglycemia in patients administered dexamethasone for craniotomy. Anesth. Analgesia 2005, 100:1129-1133.
91. Markovic A., Todorovic L. Effectiveness of dexamethasone and low-power laser in minimizing oedema after third molar surgery: a clinical trial. Int. J. Oral Maxillofac. Surg. 2007, 36:226-229.
92. Matyszak M.K., Perry V.H. The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience 1996, 74:599-608.
93. Yeh T.F., Torre J.A., Rastogi A., Anyebuno M.A., Pildes R.S. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J. Pediatr. 1990, 117:273-282.
94. Wang D.L., Wung B.S., Shyy Y.J., Lin C.F., Chao Y.J., Usami S., et al. Mechanical strain induces monocyte chemotactic protein-1 gene expression in endothelial cells. Effects of mechanical strain on monocyte adhesion to endothelial cells. Circ. Res. 1995, 77:294-302.
95. Iqbal J., Zaidi M. Molecular regulation of mechanotransduction. Biochem. Biophys. Res. Commun. 2005, 328:751-755.
96. Willis D., Li K.W., Zheng J.Q., Chang J.H., Smit A.B., Kelly T., et al. Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons. J. Neurosci. 2005, 25:778-791.
97. Calderwood S.K., Mambula S.S., Gray P.J. Extracellular heat shock proteins in cell signaling and immunity. Ann. N. Y. Acad. Sci. 2007, 1113:28-39.
98. Kountz D.S., Clark C.L. Safely withdrawing patients from chronic glucocorticoid therapy. Am. Fam. Physician 1997, 55(521-5):9-30.
99. Greenspan F.S., Gardner D.G., Shoback D. Basic & Clinical Endocrinology 1997, Appleton & Lange Stamford, CT.
100. Hempen C., Weiss E., Hess C.F. Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?. Support. Care Cancer 2002, 10:322-328.
101. Koehler P. Use of corticosteroids in neuro-oncology. Anti-Cancer Drugs 1995, 6:19-33.
102. Raison C.L., Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry 2003, 160:1554-1565.
103. Chrousos G.P. Stress and disorders of the stress system. Nat. Rev. Endocrinol. 2009, 5:374-381.
104. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 2007, 87:873-904.
105. Kozai T.D.Y., Jaquins-Gerstl A.S., Vazquez A.L., Michael A.C., Cui X.T. Brain tissue responses to neural implants impact signal sensitivity and intervention strategies. ACS Chem. Neurosci. 2015, 6:48-67.
106. Rousche P.J., Normann R.A. Chronic recording capability of the Utah Intracortical Electrode Array in cat sensory cortex. J. Neurosci. Methods 1998, 82:1-15.
107. Williams J.C., Rennaker R.L., Kipke D.R. Long-term neural recording characteristics of wire microelectrode arrays implanted in cerebral cortex. Brain Res. Brain Res. Protoc. 1999, 4:303-313.
108. Alba N.A., Du Z., Catt K, Kozai TDY, Cui XT In vivo electrochemical analysis of a PEDOT/MWCNT neural electrode. Biosensors 2015, 5:618-648.